(Q35799730)

English

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients

scientific article published on 18 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

object named as

Simone Cesaro

1

0 references

Franco Locatelli

3

object named as

Franco Locatelli

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Mareva Giacchino

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Monica Spiller

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Barbara Buldini

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Claudia Castellini

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Desireè Caselli

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Eugenia Giraldi

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Fabio Tucci

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Gloria Tridello

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mario Renato Rossi

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Elio Castagnola

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

18 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

18 April 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1471-2334-7-28

0 references

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Antifungal combination therapy: clinical potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Combination antifungal therapy: where are we now, and where are we going?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Toward more effective antifungal therapy: the prospects of combination therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Aspergillosis in children with cancer: A 34-year experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871594

11 July 2018

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Combination antifungal therapy for invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous ste

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Fungal Infections in Children With Cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-7-28

21 January 2018

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17442100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Italian guidelines for the management of infectious complications in pediatric oncology: empirical antimicrobial therapy of febrile neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17442100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17442100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17442100

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-7-28

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35799730&oldid=1803017275"